Evidence map›Paper›PMID 35301246›Full record

ArticleThe European respiratory journal2022

Epidemiological cut-off values for a 96-well broth microdilution plate for high-throughput research antibiotic susceptibility testing of

CRyPTIC Consortium

Open access · hybridAbstract read
In one paragraph

Article in The European respiratory journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 2 pooled it
8.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 2 syntheses or guidelines pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Subpopulations in clinical samples ofJAC-antimicrobial resistance · 2025
    Article
  17. Article
  18. Article
  19. Sentinel-Site-Based Surveillance ofAntibiotics (Basel, Switzerland) · 2025
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

CRyPTIC Consortium
University of Oxford · GB

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007365 · NIGMS · STANFORD UNIVERSITY · PI CHUA, KATRIN F · 1985 to 2021
$33.8M
Using the Mycobacterium tuberculosis Genome to Predict Tuberculosis Pathology, Drug Resistance Acquisition and Identify Community Transmission SitesR01AI146338 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GILMAN, ROBERT H · 2020 to 2024
$3.3M
Use of whole genome sequencing for tuberculosis diagnosticsR03AI117312 · NIAID · WADSWORTH CENTER · PI ESCUYER, VINCENT E., LAPIERRE, PASCAL · 2015 to 2016
$147k
NIAID NIH HHS R01 AI146338NIAID NIH HHS R03 AI117312NIGMS NIH HHS T32 GM007365OSELS CDC HHS U60 OE000103Wellcome Trust 098316Wellcome Trust 101237Wellcome Trust 201470Wellcome Trust 203141Wellcome Trust 203583Wellcome Trust 206724Wellcome Trust 214321
6 · The paper itself

Abstract

Drug susceptibility testing of

Indexed as

Mycobacterium tuberculosisTuberculosisAnti-Bacterial AgentsHumansMicrobial Sensitivity TestsAnti-Bacterial Agents

Identifiers

PMID35301246
PMCPMC9556810
OpenAlexW4221007313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.